Emilio Ansotegui Barrera
Overview
Explore the profile of Emilio Ansotegui Barrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez Reyes R, Nauffal Manzur D, Ortega A, Menendez Salinas M, Ansotegui Barrera E, Balerdi Perez B
Clin Respir J
. 2015 Apr;
11(1):103-112.
PMID: 25919650
Background And Aims: The aim of our study was to describe the characteristics and clinical outcomes of pulmonary hypertension (PH) patients who underwent their follow-up at a single centre. Methods:...
2.
Ceron Navarro J, de Aguiar Quevedo K, Ansotegui Barrera E, Aragon C, Penalver Cuesta J, Mancheno Franch N, et al.
Arch Bronconeumol
. 2014 Aug;
51(3):109-14.
PMID: 25151535
Introduction: Lung transplantation (LT) is a therapeutic option with controversial results in chronic obstructive pulmonary disease (COPD). We aimed to analyze the outcomes of transplantation in terms of lung function...
3.
Reig Mezquida J, Sole Jover A, Ansotegui Barrera E, Escriva Peiro J, Pastor Colom M, Pastor Guillem J
Arch Bronconeumol
. 2014 Aug;
51(5):e23-4.
PMID: 25138798
Thrombotic microangiopathy (TMA) is a rare complication associated with the use of calcineurin inhibitors in lung transplantation, irrespective of the underlying disease of the graft recipient. It usually occurs in...
4.
Sanchez de Cos Escuin J, Abal Arca J, Melchor Iniguez R, Miravet Sorribes L, Nunez Ares A, Hernandez Hernandez J, et al.
Lung Cancer
. 2014 Mar;
84(2):182-9.
PMID: 24629637
Introduction: The current edition of the tumor, node and metastasis (TNM) classification of lung cancer (LC) divides the presence of metastasis (M1) into two categories: M1a and M1b, depending on...
5.
Ansotegui Barrera E, Mancheno Franch N, Penalver Cuesta J, Vera-Sempere F, Padilla Alarcon J
Med Clin (Barc)
. 2013 Aug;
141(8):349-52.
PMID: 23937818
Background And Objective: Sporadic lymphangioleiomyomatosis (S-LAM) is a rare disease that affects only women. It is characterized by an abnormal proliferation of immature smooth muscle cells (LAM cells) that grow...
6.
Ansotegui Barrera E, Mancheno Franch N, Penalver Cuesta J, Vera-Sempere F, Padilla Alarcon J
Med Clin (Barc)
. 2012 Mar;
138(13):570-3.
PMID: 22440137
Background And Objective: Lymphangioleiomyomatosis (LAM) is a rare disease characterized by an aberrant immature smooth muscle cells proliferation. This excessive growth of LAM cells around airways, parenchyma, lymphatic ganglia and...
7.
Ansotegui Barrera E, Mancheno Franch N, Vera-Sempere F, Padilla Alarcon J
Arch Bronconeumol
. 2011 Jan;
47(2):85-93.
PMID: 21255897
Lymphangioleiomyomatosis (LAM) is a rare disease that mainly affects women, particularly at fertile age. It is sporadic or associated with tuberous sclerosis complex. It is characterised by an abnormal proliferation...
8.
Roig Vazquez F, Ansotegui Barrera E, Martinez Albiach J
Arch Bronconeumol
. 2006 Sep;
42(8):417.
PMID: 16948997
No abstract available.